Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The data supporting this article have been included as part of the . Supporting Information Filename Description ardp70165-sup-0001-Updated_Supplementary_Data.docx52.5 MB Supplementary Data. Appendix A. References 1, , and , Cancer: Epidemiology, Racial, and Geographical Disparities, Molecular Biomarkers for Cancer Diagnosis and Therapy (Springer, 2024), 31–52.
1. Introduction Cancer has become a global burden due to the significant increase in cancer incidence and mortality rates [1,2]. Tumor resistance, drug toxicity, cancer recurrence, and the inadequate success rate of drug development reaching clinical trials are all limiting variables that exacerbate the difficulties in cancer treatment [3,4]. The search for novel classes of anti-cancer medications focuses on enhancing cancer patients’ treatment efficacy and survival rates.
Open AccessArticle by Hany M. Abd El-Lateef 1,2,*, Mohammed A. I. Elbastawesy 3,*, Tamer Mohamed Abdelghani Ibrahim 4,5, Mai M. Khalaf 1,2, Mohamed Gouda 1, Mariam G. F. Wahba 6, Islam Zaki 7 and Martha M.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
